{"title":"Association between ultra-processed food consumption and lung cancer risk: a population-based cohort study","authors":"Kanran Wang, Junhan Zhao, Dingyi Yang, Mao Sun, Wei Zhou, Yongzhong Wu","doi":"10.1136/thorax-2024-222100","DOIUrl":null,"url":null,"abstract":"Background The evidence on associations between ultra-processed foods (UPF) and lung cancer risk is limited and inconsistent. Research question Are UPF associated with an increased risk of lung cancer, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)? Methods Data of participants in this study were collected from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Dietary intakes were assessed through a validated diet history questionnaire. These foods were categorised using the NOVA classification according to the degree of processing in the PLCO Cancer Screening Cohort. All cases of incident lung cancer were pathologically verified. Multivariable Cox regression was used to assess the association between consumption of UPF and lung cancer after adjustment for various potential confounders, including key risk factors related to lung cancer and overall diet quality. Results A total of 1706 cases of lung cancer cases, including 1473 NSCLC and 233 SCLC, were identified during a mean follow-up of 12.2 years among 101 732 adults (mean age 62.5 years). After multivariable adjustments, individuals in the highest quarters for UPF consumption had a higher risk of lung cancer (HR=1.41, 95% CI 1.22 to 1.60), NSCLC (HR=1.37, 95% CI 1.20 to 1.58) and SCLC (HR=1.44, 95% CI 1.03 to 2.10) compared with those in the lowest quarter. These results remained statistically significant after a large range of subgroup and sensitivity analyses. Conclusions Higher consumption of UPF is associated with an increased risk of lung cancer, NSCLC and SCLC. Although additional research in other populations and settings is warranted, these findings suggest the healthy benefits of limiting UPF. Data may be obtained from a third party and are not publicly available. Data described in the manuscript, code book and analytic code will not be made available because the authors are prohibited from distributing or transferring the data and code books on which their research was based to any other individual or entity under the terms of an approved NCI Research Proposal and Data and Materials Distribution Agreement through which the authors obtained these data.","PeriodicalId":23284,"journal":{"name":"Thorax","volume":"26 1","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thorax","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/thorax-2024-222100","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Background The evidence on associations between ultra-processed foods (UPF) and lung cancer risk is limited and inconsistent. Research question Are UPF associated with an increased risk of lung cancer, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)? Methods Data of participants in this study were collected from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Dietary intakes were assessed through a validated diet history questionnaire. These foods were categorised using the NOVA classification according to the degree of processing in the PLCO Cancer Screening Cohort. All cases of incident lung cancer were pathologically verified. Multivariable Cox regression was used to assess the association between consumption of UPF and lung cancer after adjustment for various potential confounders, including key risk factors related to lung cancer and overall diet quality. Results A total of 1706 cases of lung cancer cases, including 1473 NSCLC and 233 SCLC, were identified during a mean follow-up of 12.2 years among 101 732 adults (mean age 62.5 years). After multivariable adjustments, individuals in the highest quarters for UPF consumption had a higher risk of lung cancer (HR=1.41, 95% CI 1.22 to 1.60), NSCLC (HR=1.37, 95% CI 1.20 to 1.58) and SCLC (HR=1.44, 95% CI 1.03 to 2.10) compared with those in the lowest quarter. These results remained statistically significant after a large range of subgroup and sensitivity analyses. Conclusions Higher consumption of UPF is associated with an increased risk of lung cancer, NSCLC and SCLC. Although additional research in other populations and settings is warranted, these findings suggest the healthy benefits of limiting UPF. Data may be obtained from a third party and are not publicly available. Data described in the manuscript, code book and analytic code will not be made available because the authors are prohibited from distributing or transferring the data and code books on which their research was based to any other individual or entity under the terms of an approved NCI Research Proposal and Data and Materials Distribution Agreement through which the authors obtained these data.
超加工食品(UPF)与肺癌风险之间关联的证据有限且不一致。研究问题:UPF是否与肺癌、非小细胞肺癌(NSCLC)和小细胞肺癌(SCLC)的风险增加有关?方法本研究的参与者资料来自前列腺、肺、结直肠和卵巢(PLCO)癌症筛查试验。通过有效的饮食史问卷评估饮食摄入量。根据PLCO癌症筛查队列中的加工程度,使用NOVA分类对这些食物进行分类。所有病例均经病理证实为肺癌。在调整各种潜在混杂因素(包括与肺癌相关的关键危险因素和整体饮食质量)后,使用多变量Cox回归评估UPF消费与肺癌之间的关系。结果101 732例成人(平均年龄62.5岁)平均随访12.2年,共发现肺癌病例1706例,其中NSCLC 1473例,SCLC 233例。在多变量调整后,UPF消费最高季度的个体与最低季度的个体相比,肺癌(HR=1.41, 95% CI 1.22至1.60)、NSCLC (HR=1.37, 95% CI 1.20至1.58)和SCLC (HR=1.44, 95% CI 1.03至2.10)的风险更高。在大范围的亚组和敏感性分析后,这些结果仍然具有统计学意义。结论:UPF的高消耗与肺癌、非小细胞肺癌和小细胞肺癌的风险增加有关。虽然需要在其他人群和环境中进行进一步的研究,但这些发现表明限制UPF对健康有益。数据可能会从第三方获得,并且不会公开提供。在手稿、代码本和分析代码中描述的数据将不会被提供,因为作者被禁止根据批准的NCI研究计划和数据和材料分发协议的条款向任何其他个人或实体分发或转让其研究所基于的数据和代码本,作者通过这些数据获得这些数据。
期刊介绍:
Thorax stands as one of the premier respiratory medicine journals globally, featuring clinical and experimental research articles spanning respiratory medicine, pediatrics, immunology, pharmacology, pathology, and surgery. The journal's mission is to publish noteworthy advancements in scientific understanding that are poised to influence clinical practice significantly. This encompasses articles delving into basic and translational mechanisms applicable to clinical material, covering areas such as cell and molecular biology, genetics, epidemiology, and immunology.